Jorge A. Gallardo-Cartagena

机构：National University of San Marcos · ORCID：0000-0001-5142-1954

发表论文 26 篇 · 总被引 1322 次 · h-index 8

代表论文

• Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women (2021 · New England Journal of Medicine · 被引 913)
• Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons (2024 · New England Journal of Medicine · 被引 285)
• Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody (2021 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 28)
• Clinical and Immunologic Outcomes After Immediate or Deferred Antiretroviral Therapy Initiation During Primary Human Immunodeficiency Virus Infection: The Sabes Randomized Clinical Study (2020 · Clinical Infectious Diseases · 被引 26)
• Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region (2023 · Journal of Global Health · 被引 19)
• Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial (2023 · The Lancet HIV · 被引 16)